Table 2.
Baseline pathogens with incidence ≥ 1% by treatment group and overall
| Organism | Treatment group, N (%) | |||
|---|---|---|---|---|
| Besifloxacin ophthalmic suspension, 0.6% | Moxifloxacin ophthalmic solution, 0.5% | Vehicle | Overall | |
| All species | 656 (100.0) | 370 (100.0) | 298 (100.0) | 1324 (100.0) |
| Haemophilus influenzae | 167 (25.5) | 90 (24.3) | 87 (29.2) | 344 (26.0) |
| Streptococcus pneumoniae | 153 (23.3) | 66 (17.8) | 83 (27.9) | 302 (22.8) |
| Staphylococcus aureus | 93 (14.2) | 56 (15.1) | 41 (13.8) | 190 (14.4) |
| Staphylococcus epidermidis | 50 (7.6) | 41 (11.1) | 20 (6.7) | 111 (8.4) |
| Streptococcus mitis groupa | 19 (2.9) | 14 (3.8) | 12 (4.0) | 45 (3.4) |
| CDC coryneform group G | 16 (2.4) | 11 (3.0) | 2 (0.7) | 29 (2.2) |
| Streptococcus mitis | 10 (1.5) | 5 (1.4) | 5 (1.7) | 20 (1.5) |
| Streptococcus oralis | 11 (1.7) | 4 (1.1) | 3 (1.0) | 18 (1.4) |
| Streptococcus spp.a | 8 (1.2) | 3 (0.8) | 2 (0.7) | 13 (1.0) |
a
Note: Isolates that were identified to the species level were listed separately.